Full Health Medical, an Irish medtech company, has raised €3 million to develop its health screening technology and expand its footprint beyond Ireland and the UK.

The round was led by Irish investment firm Elkstone, with backing from Enterprise Ireland and a number of angel investors. The funding will be used to complete development of the company's next-generation platform, pursue medical device certification and enter new markets.

Full Health Medical's platform manages the logistics of running screening programmes while using algorithms developed by medical consultants to interpret patient results. The system is designed to reduce the manual review burden on doctors, allowing a single doctor to review and deliver results to more patients each day, which the company says could help reduce waiting times. More than 500,000 medical assessments have been processed through the technology to date, with clients across Ireland and the UK.

The company was co-founded by emergency medicine consultant Dr Ann Shortt and Paul McCarthy. Dermot Shortt has joined as chief executive and Rizwan Saeed as chief technology officer, both previously of UBS Investment Bank, with Mr Shortt having gone on to co-found financial technology company Finbourne Technology. Full Health Medical is also transitioning from a services-based model to a software-as-a-service business.

"In my many years of experience as an emergency medicine consultant, I've seen first-hand the growing pressure on healthcare systems and the consequences of rising demand, constrained resources and delayed intervention," said Dr Shortt. "We need a cultural shift towards prevention. We can only make a meaningful change by equipping individuals with the tools to understand their own health data. By empowering people to take control of their health, we will see a population that lives well for longer and seeks help earlier when intervention is needed."

The structural driver behind the raise is a state-supported push to shift healthcare capacity toward earlier, preventive screening as doctor availability remains constrained, with Enterprise Ireland's participation reflecting continued state co-investment in scaling indigenous health-tech platforms alongside private capital.

For the sector, the round reflects growing private and state appetite for software-led screening tools that expand doctor capacity rather than simply digitising existing services.

Source: independent.ie